Skip to main content

Jason Gerberry

Analyst

ICUFer Pharma and Biotech

Equibles does not estimate personal net worth.

About Jason Gerberry

Jason Gerberry is recorded as Analyst at ICUFer Pharma and Biotech. Jason Gerberry has spoken on 1 investor event across 1 company, most recently for Fractyl Health, Inc. on May 14, 2026. The companies whose calls Jason Gerberry spoke on are classified in the Healthcare sector.

Jason Gerberry on recent calls

“We're going to get going here at the B of A Annual Healthcare Conference in our last company presentation with Fractal Health. My name is Jason Gerberry. I am iCupfer Pharma and Biotech here at B of A, and we're joined by Harith Rajapalan, co-founder and CEO, and Lisa Smith-Weber, CFO.”
Analyst — ICUFer Pharma and Biotech, BofA Securities 2026 Health Care Conference ·

Affiliation history

  • ICUFer Pharma and Biotech

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity